Citation

Barbour V. Med. J. Aust. 2023; 218(6).

Copyright

(Copyright © 2023, Australian Medical Association, Publisher Australasian Medical Publishing)

DOI

10.5694/mja2.51893

PMID

unavailable

Abstract

The article featured on the cover of this issue of the MJA describes an important approach to eliminating hepatitis C, a disease predominantly transmitted in developed countries through injecting drug use. Given the advent of highly effective and well tolerated direct‐acting antiviral (DAA) therapies, the Australian Government has adopted elimination of hepatitis C as a feasible objective. A major challenge, however, is getting the treatment to individuals with hepatitis C in a timely and appropriate way. As MacIsaac and colleagues note in their research article, "Engaging people who inject drugs with hepatitis C testing and treatment will be crucial to elimination". They describe the experience in the first supervised injecting facility in Victoria, which opened in 2018 in inner metropolitan Melbourne. The results are encouraging and suggest that providing treatment in this type of facility is effective and offers hope for the future. The authors report that "DAA treatment was prescribed for 126 of 143 HCV RNA‐positive clients" and that "41 of 54 with complete follow‐up data were cured" (doi: 10.5694/mja2.51885).

A research letter and editorial examine the investigation of sudden unexpected death in infancy (SUDI) in Australia. Jeffery and colleagues note that although "SUDI requires thorough investigation according to international standards and guidelines", before their study it was unknown how well these standards were implemented in Australia. Their survey of all eight Australian jurisdictions found that most Australian investigations are police‐led and rely on the limited histories collected by the police. The authors recommend that the process of investigation of SUDI in Australia be upgraded to international standards: "every family has the right to have their child's death properly investigated" (doi: 10.5694/mja2.51833). In a linked editorial, Goldwater agrees, arguing that "SUDI investigations should be led by coroners, supported by experienced paediatric pathologists" (doi: 10.5694/mja2.51884).

Language: en